Anti-cancer medications that can lessen the impact of malignant cells in pets are known as veterinary cancer therapies. Depending on the nature and stage of the disease, cancer therapies for dogs can be monotherapy or combination therapy.
The increased incidence of cancer in animals throughout the world is one of the key factors driving the pet cancer therapeutics market's rise. Furthermore, the sector is being propelled ahead by increasing animal domestication and consumer awareness of pet health. In cats and some breeds of older dogs, long-term exposure to ultraviolet (UV) rays, secondhand cigarette smoke, herbicides, pesticides, insecticides, and air pollution can cause leukaemia and lymphoma. As a result, as individuals become more aware of the benefits of early diagnosis and the treatment choices available, the market is rising.
With their novel therapies, prominent companies with a broad product portfolio are projected to grow pet cancer therapeutics market share. Market expansion will be limited by the negative effects of pet cancer medications and a lack of understanding about pet illnesses among pet owners.
Read more @ https://cmiaspireblog.blogspot.com/2021/10/pet-cancer-therapeutics-market-size.html
